NIH-funded research R01 grant

Investigating how a specific receptor affects inflammation and lung injury.

Official title: Nuclear receptor, PPARg in macrophage polarization, hyperinflammatory gene expression and lung injury

Funded at Johns Hopkins University · NIH-11061269 · Data updated 2026-11-12

This study is looking at how a specific protein in our cells helps immune cells called macrophages respond when the lungs are hurt or inflamed, with the goal of finding new ways to treat lung problems.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionJohns Hopkins University
NIH-funded
Lab location1 site (Baltimore, United States)
Project startApril 1, 2024
Project endMarch 31, 2028
Funding year2025
Award (this year)$644,093
NIH project number5R01HL170426-06
Project IDNIH-11061269 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals experiencing acute lung injury or chronic inflammatory lung conditions.

Less likely to help

Patients with stable lung conditions or those not experiencing acute inflammation may not benefit from this research.

What this research studies

This research focuses on understanding the role of the nuclear receptor PPARγ in regulating macrophage behavior during lung injury and inflammation. By examining how macrophages respond to injury and the factors that influence their polarization, the study aims to uncover the mechanisms behind hyperinflammatory responses. The research employs advanced techniques to analyze gene expression and epigenomic changes in macrophages, which could lead to new therapeutic strategies for lung-related conditions.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for acute lung injuries and related inflammatory diseases.

How similar studies have gone: Previous research has shown promising results in understanding macrophage polarization and its implications for inflammation, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Johns Hopkins University
    Baltimore, United States
    Active

Researchers

  • Principal investigator: Nagy, Laszlo — Johns Hopkins University
  • Study coordinator: Nagy, Laszlo

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.